2009
DOI: 10.1016/j.regpep.2008.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of compensatory renal growth by the N-terminus of a sheep-derived peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(21 citation statements)
references
References 28 publications
0
21
0
Order By: Relevance
“…Rabbits at a supplier (Eurogentec, Liège, Belgium) were injected subcutaneously with the antigen (400 μg protein) in PBS mixed with an equal volume of complete Freund’s adjuvant followed by subsequent injections at monthly intervals in Freund’s incomplete adjuvant. An ELISA dilution curve for the rabbit polyclonal antiserum (ER88) has been provided elsewhere ( Haylor et al, 2009 ). A polyclonal antiserum (G530) was raised in goat (Monash University, Victoria, Australia) in a similar manner ( Hart, 2013 ) and an antibody ELISA dilution curve obtained using the same standard methodology ( Haylor et al, 2009 ).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Rabbits at a supplier (Eurogentec, Liège, Belgium) were injected subcutaneously with the antigen (400 μg protein) in PBS mixed with an equal volume of complete Freund’s adjuvant followed by subsequent injections at monthly intervals in Freund’s incomplete adjuvant. An ELISA dilution curve for the rabbit polyclonal antiserum (ER88) has been provided elsewhere ( Haylor et al, 2009 ). A polyclonal antiserum (G530) was raised in goat (Monash University, Victoria, Australia) in a similar manner ( Hart, 2013 ) and an antibody ELISA dilution curve obtained using the same standard methodology ( Haylor et al, 2009 ).…”
Section: Methodsmentioning
confidence: 99%
“…An ELISA dilution curve for the rabbit polyclonal antiserum (ER88) has been provided elsewhere ( Haylor et al, 2009 ). A polyclonal antiserum (G530) was raised in goat (Monash University, Victoria, Australia) in a similar manner ( Hart, 2013 ) and an antibody ELISA dilution curve obtained using the same standard methodology ( Haylor et al, 2009 ). Titre was also established via IHC, using rat and ovine median eminence tissue (basal hypothalamus), and the ability to block antibody with EPL001 was determined on histological sections at 0.5 mg/ml.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The peptide EPL001 arose from a hormone discovery programme directed at finding an endogenous tissue-mass inhibitor in mammals (Haylor et al, 2009;Hart, 2014). An N-terminal sequence of 14 amino acids was obtained from ovine material, but bioinformatics failed to identify the parent molecule.…”
Section: Introductionmentioning
confidence: 99%
“…A 14mer peptide corresponding to this N-terminal sequence was synthesized. It was designated EPL001 and shown to have biological activity: inhibition of compensatory renal growth was observed in the rat following unilateral nephrectomy (Haylor et al, 2009). As this system is associated with IGF1 and the related DAF2 pathway is known to be important in longevity and reproduction in C. elegans (Baumeister et al, 2006), it was of interest to test EPL001 in this nematode in terms of lifespan and fecundity (Davies and Hart, 2008).…”
Section: Introductionmentioning
confidence: 99%